News By Tag
News By Place
Follow on Google News
Tuberculosis Treatment Market Trends 2022
A recent report published by Precision Business Insights on Tuberculosis Treatment Market provides an in-depth analysis of segments and sub-segments in the global as well as regional.
View Detailed Report Description at https://precisionbusinessinsights.com/
The global tuberculosis treatment market segmentation:
1) By Class of Drugs: First Line Drugs, Second Line Drugs)
2) By TB: B, Multi-Drug Resistance TB
3) By route of administration:
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others
Asia Pacific led the market, with a share of x percent. This is due to the disease's higher incidence, rising prevalence of HIV-TB co-infection, greater public knowledge of the dangers of drug non-compliance, and improved health systems. In terms of API production, China and India are major players in the APAC industry.
There are several industry players working in the tuberculosis treatment market, which include Bayer AG (Germany), AstraZeneca PLC (U.S.), GlaxoSmithKline PLC (U.S.), Eli Lilly And Company (U.S.), Novartis AG (Switzerland ), Lupin Pharmaceuticals Inc. (India), Sandoz International GmbH (Germany), Pfizer Inc. (U.S.), Johnson & Johnson Services Inc. (U.S.), Sanofi S.A. (France)
Precision Business Insights